Research
Education
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Regional Infectious Diseases Unit
Daire O'Shea has not added Biography.
If you are Daire O'Shea and would like to personalize this page please email our Author Liaison for assistance.
An analysis of regulatory T-cell and Th-17 cell dynamics during cytomegalovirus replication in solid organ transplant recipients.
PloS one , 2012 | Pubmed ID: 23071829
Comparison of the effect of standard and novel immunosuppressive drugs on CMV-specific T-cell cytokine profiling.
Transplantation Feb, 2013 | Pubmed ID: 23274966
Cross-sectional study of the characteristics, healthcare usage, morbidity and mortality of injecting drug users attending an inner city emergency department.
Emergency medicine journal : EMJ Aug, 2014 | Pubmed ID: 23625509
Variation in both IL28B and KIR2DS3 genes influence pegylated interferon and ribavirin hepatitis C treatment outcome in HIV-1 co-infection.
PloS one , 2013 | Pubmed ID: 23826153
Life-threatening infection in transplant recipients.
Critical care clinics Oct, 2013 | Pubmed ID: 24094386
Immunomodulatory Function of Interleukin 28B during primary infection with cytomegalovirus.
The Journal of infectious diseases Sep, 2014 | Pubmed ID: 24620020
Vaccine adjuvants--understanding molecular mechanisms to improve vaccines.
Swiss medical weekly , 2014 | Pubmed ID: 24844935
Changing face of vaccination in immunocompromised hosts.
Current infectious disease reports Sep, 2014 | Pubmed ID: 24992978
IL-28B is a key regulator of B- and T-cell vaccine responses against influenza.
PLoS pathogens Dec, 2014 | Pubmed ID: 25503988
Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination.
The Journal of infectious diseases Jul, 2015 | Pubmed ID: 25589334
The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections.
Emerging microbes & infections Jul, 2014 | Pubmed ID: 26038748
Prevention of hepatitis C virus infection using a broad cross-neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society Mar, 2016 | Pubmed ID: 26389583
University of Edinburgh
Mohameedyaseen Syedbasha1,
Janina Linnik1,2,3,
Deanna Santer4,
Daire O'Shea5,
Khaled Barakat4,6,
Michael Joyce4,
Nina Khanna7,
D. Lorne Tyrrell4,
Michael Houghton4,
Adrian Egli1,8
1Applied Microbiology Research, Department of Biomedicine, University of Basel,
2Department of Biosystems Science and Engineering, ETH Zurich, and Swiss Institute of Bioinformatics,
3, Swiss Institute of Bioinformatics,
4Li Ka Shing Institute for Virology, University of Alberta,
5Regional Infectious Diseases Unit, University of Edinburgh,
6Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta,
7Infection Biology, Department of Biomedicine, University of Basel,
8Clinical Microbiology, University Hospital Basel
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Librarians
Access
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved